Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
Miyagawa
S
S
First Department of Surgery, Osaka University Medical School, Japan.
Shirakura
R
R
Matsumiya
G
G
Nakata
S
S
Matsuda
H
H
Hatanaka
M
M
Matsumoto
M
M
Seya
T
T
D000818:Animals; D015703:Antigens, CD / Q000276:immunology / Q000627:therapeutic use*; D018958:CD55 Antigens; D018957:CD59 Antigens; D003169:Complement Inactivator Proteins / Q000627:therapeutic use*; D003165:Complement System Proteins / Q000276:immunology*; D017707:Erythrocyte Transfusion; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006168:Guinea Pigs; D006461:Hemolysis; D006801:Humans; D008562:Membrane Glycoproteins / Q000276:immunology / Q000627:therapeutic use*; D012756:Sheep; D013045:Species Specificity; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*
D015703:Antigens, CD; D018958:CD55 Antigens; D018957:CD59 Antigens; D003169:Complement Inactivator Proteins; D008562:Membrane Glycoproteins; D003165:Complement System Proteins